Publicacions en què col·labora amb ALFONSO MORENO GONZÁLEZ (14)

2018

  1. Velázquez. Farmacología básica y clínica

    Editorial Médica Panamericana

2012

  1. Response letter to Malafarina and colleagues

    Journal of the American Geriatrics Society

  2. Velázquez. Manual de farmacología básica y clínica

    Editorial Médica Panamericana

2011

  1. Risk of cerebrovascular accident associated with use of antipsychotics: Population-based case-control study

    Journal of the American Geriatrics Society, Vol. 59, Núm. 7, pp. 1182-1187

2006

  1. Lack of pharmacokinetic interaction between omeprazole or lansoprazole and ivabradine in healthy volunteers: An open-label, randomized, crossover, pharmacokinetic interaction clinical trial

    Journal of Clinical Pharmacology, Vol. 46, Núm. 10, pp. 1195-1203

2004

  1. Truncated AUC in the evaluation of fluconazole bioequivalence: A cross-over, randomised, open-label study in healthy volunteers

    Arzneimittel-Forschung/Drug Research, Vol. 54, Núm. 11, pp. 752-756

  2. Velázquez. Farmacología Básica y Clínica

    Editorial Médica Panamericana S.A.

2003

  1. Effect of adverse drug reactions on length of stay in surgical intensive care units

    Critical Care Medicine, Vol. 31, Núm. 3, pp. 694-698

2002

  1. Pharmacokinetic study of a new ibuprofen 600mg plus codeine 30mg combination versus ibuprofen or codeine alone in single oral doses in healthy volunteers

    Clinical Drug Investigation, Vol. 22, Núm. 1, pp. 41-49

2001

  1. Comparative single-dose bioavailability study of two oral formulations of ibuprofen in healthy volunteers

    Clinical Drug Investigation, Vol. 21, Núm. 5, pp. 383-389

2000

  1. Modification of albumin use pattern after an educational intervention

    Disease Management and Health Outcomes, Vol. 8, Núm. 1, pp. 43-50

1997

  1. Use of albumin in two Spanish university hospitals

    European Journal of Clinical Pharmacology, Vol. 52, Núm. 6, pp. 465-470

  2. Use of intravenous omeprazole in a university hospital

    Journal of Pharmacy Technology, Vol. 13, Núm. 1, pp. 32-35

1996

  1. Adverse drug reactions in a cardiology department. Cause of admission or appearance during hospitalisation

    Clinical Drug Investigation, Vol. 12, Núm. 1, pp. 46-52